User menu

Pharmacokinetics and safety of LY334370, a novel oral 5-HT1F selective agonist, in patients during migraine.

Bibliographic reference Granier, LA ; De Suray, JM ; Pereira, A. Pharmacokinetics and safety of LY334370, a novel oral 5-HT1F selective agonist, in patients during migraine..In: Clinical Pharmacology and Therapeutics, Vol. 65, no. 2, p. 129-129 (1999)
Permanent URL http://hdl.handle.net/2078.1/62339